Exploring the Potential of Gene Therapies for Limb-girdle Muscular Dystrophies
Dr. Louise Rodino-Klapac discusses the science of limb-girdle muscular dystrophies (LGMDs) and how our gene therapy engine will help engineer potential therapies for this group of inherited neuromuscular diseases.

Sarepta's gene therapy engine at work in LGMD2E research
Sarepta’s gene therapy engine provides a framework for creating a steady stream of new therapies for devastating diseases, such as limb-girdle muscular dystrophies.
Press Releases 澳洲5开官网开奖记录查询历史 澳洲幸运五官网官方查询结果 168体彩开奖号码结果记录查阅
Spotlight
The Complexities of Gene Therapy Manufacturing
Learn more about what goes into manufacturing gene therapies and Sarepta’s approach to meeting the challenges inherent in making these transformative therapies a reality for patients with rare diseases.
澳洲幸运五官网开奖网站 / 奥5手机网在线开奖视频现场直播 Highlights
Our FDA-Approved Treatments
Lean more about our FDA-approved treatments.
A Day in The Life at Sarepta
Hear from employees and how our mission drives their work.